Related Experiment Video
Updated: Mar 14, 2026

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
Published on: April 18, 2019
Unveiling the Synergistic Interaction Between Liposomal Amphotericin B and Colistin
Rita Teixeira-Santos1, Elisabete Ricardo2, Ricardo J Branco3
1Department of Microbiology, Faculty of Medicine, University of Porto Porto, Portugal.
Abstract:
Patients with multiple comorbidities are often administered simultaneously or sequentially antifungals and antibacterial agents, without full knowledge of the consequences of drug interactions. Considering the clinical relevance of liposomal amphotericin B (L-AMB), the association between L-AMB and six antibacterial agents was evaluated against four clinical isolates and one type strain of Candida spp. and two clinical isolates and one type strain of Aspergillus fumigatus. In order to evaluate such combined effects, the minimal inhibitory concentration (MIC) of L-AMB was determined in the presence of 0.5-, 1-, 2-, and 4-fold peak plasma concentrations of each of the antibacterial drugs. Since the L-AMB/colistin (CST) association was the most synergic, viability assays were performed and the physiological status induced by this association was characterized. In addition, computational molecular dynamics studies were also performed in order to clarify the molecular interaction. The maximum synergistic effect with all antibacterial agents, except CST, was reached at fourfold the usual peak plasma concentrations, resulting in 2-to 8-fold L-AMB MIC reduction for Candida and 2-to 16-fold for Aspergillus. For CST, the greatest synergism was registered at peak plasma concentration (3 mg/L), with 4-to 8-fold L-AMB MIC reduction for Candida and 16-to 32-fold for Aspergillus. L-AMB at subinhibitory concentration (0.125 mg/L) combined with CST 3 mg/L resulted in: a decrease of fungal cell viability; an increase of cell membrane permeability; an increase of cellular metabolic activity soon after 1 h of exposure, which decreased until 24 h; and an increase of ROS production up to 24 h. From the molecular dynamics studies, AMB and CST molecules shown a propensity to form a stable molecular complex in solution, conferring a recognition and binding added value for membrane intercalation. Our results demonstrate that CST interacts synergistically with L-AMB, forming a stable complex, which promotes the fungicidal activity of L-AMB at low concentration.
Insights
This study shows that colistin (CST) enhances liposomal amphotericin B (L-AMB) antifungal activity against Candida and Aspergillus. Their combination forms a stable complex, increasing L-AMB
Area of Science:
- Mycology
- Pharmacology
- Computational Biology
Background:
- Drug interactions between antifungals and antibacterials are clinically relevant but poorly understood.
- Liposomal amphotericin B (L-AMB) is a critical antifungal agent.
- Co-administration of antimicrobials necessitates evaluating potential drug interactions.
Purpose of the Study:
- To investigate the synergistic effects of L-AMB combined with various antibacterial agents.
- To characterize the physiological and molecular interactions of synergistic L-AMB combinations.
- To determine the impact on Candida and Aspergillus species.
Main Methods:
- Minimal Inhibitory Concentration (MIC) assays of L-AMB in the presence of different concentrations of six antibacterial agents.
- Fungal viability assays, membrane permeability, metabolic activity, and ROS production measurements.
- Computational molecular dynamics simulations to elucidate molecular interactions.
Main Results:
- Colistin (CST) demonstrated the most significant synergy with L-AMB across all tested fungal strains.
- L-AMB/CST combination significantly reduced fungal viability and increased membrane permeability.
- Molecular dynamics revealed a stable complex formation between L-AMB and CST, enhancing membrane intercalation.
Conclusions:
- Colistin exhibits strong synergistic antifungal activity with liposomal amphotericin B.
- The L-AMB/CST complex enhances L-AMB's fungicidal efficacy at lower concentrations.
- This combination holds promise for treating invasive fungal infections in polymedicated patients.
More Related Videos
07:51High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
Published on: May 21, 2018
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Drugs that Destabilize Microtubules
Pharmacokinetics: Drug–Drug Interactions
Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration